These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 4801608)
1. [Planning for Phase I in clinico-pharmacological research]. Dudeck J; Höbel W; Valk HU Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1625-8. PubMed ID: 4801608 [No Abstract] [Full Text] [Related]
2. [Experience with phase I of clinical pharmacology in the registration of drugs]. von Eickstedt KW Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1677-8. PubMed ID: 4801617 [No Abstract] [Full Text] [Related]
3. Proceedings: Statistical considerations in the planning and analysis of pharmacokinetic experiments. Westlake WJ Acta Pharm Suec; 1974 Dec; 11(6):632. PubMed ID: 1136784 [No Abstract] [Full Text] [Related]
4. [Clinico-chemical research in phase I of drug testing in humans]. Wolf HP Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1629-31. PubMed ID: 4801609 [No Abstract] [Full Text] [Related]
5. [MASCA-model of the biochemical-pharmacological drug research. Part 2: Multivariate test criterions and methods (author's transl)]. Mager PP Arzneimittelforschung; 1975 Aug; 25(8):1270-2. PubMed ID: 1242357 [No Abstract] [Full Text] [Related]
6. [Phase I studies on healthy test subjects and patients]. Zapf RM; Rupp W Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1638-40. PubMed ID: 4205543 [No Abstract] [Full Text] [Related]
10. An overview of some pharmacological methods used in safety pharmacology studies. Pugsley MK Proc West Pharmacol Soc; 2004; 47():18-22. PubMed ID: 15633602 [TBL] [Abstract][Full Text] [Related]
11. Initial human trials with an investigational new drug (phase I and 2): planning an management. Vaidya AB; Vaidya RA J Postgrad Med; 1981 Oct; 27(4):197-213. PubMed ID: 7338825 [No Abstract] [Full Text] [Related]
12. [Use of mathematical methods of planning an experiment in biomedical research]. Lisenkov AN Vestn Akad Med Nauk SSSR; 1973; 28(5):78-84. PubMed ID: 4777455 [No Abstract] [Full Text] [Related]
13. The use of stable isotopes in pharmacological research. Baillie TA Pharmacol Rev; 1981 Jun; 33(2):81-132. PubMed ID: 7029573 [No Abstract] [Full Text] [Related]
14. Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations. Gabrielsson J; Dolgos H; Gillberg PG; Bredberg U; Benthem B; Duker G Drug Discov Today; 2009 Apr; 14(7-8):358-72. PubMed ID: 19162219 [TBL] [Abstract][Full Text] [Related]
15. Spectral mapping, a technique for classifying biological activity profiles of chemical compounds. Lewi PJ Arzneimittelforschung; 1976; 26(7):1295-1300. PubMed ID: 1036914 [TBL] [Abstract][Full Text] [Related]
16. Models and methods for the assessment of cumulation of drug effects. Brock N; Schneider B Arzneimittelforschung; 1980; 30(7):1034-40. PubMed ID: 7191283 [No Abstract] [Full Text] [Related]
17. "Getting the dose right": facts, a blueprint, and encouragements. Peck CC; Cross JT Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068 [No Abstract] [Full Text] [Related]
18. Application of statistical 'design of experiments' methods in drug discovery. Tye H Drug Discov Today; 2004 Jun; 9(11):485-91. PubMed ID: 15149624 [TBL] [Abstract][Full Text] [Related]
19. [Biometry and clinical pharmacology. Analysis of time depending datas in biomedical research]. Rahlfs VW; Bedall FK Int Z Klin Pharmakol Ther Toxikol; 1971 Aug; 5(1):96-109. PubMed ID: 5570064 [No Abstract] [Full Text] [Related]
20. [Rational biometric methods used in determining the biological activity of drugs]. Flerovskiĭ AA Eksp Klin Farmakol; 1999; 62(5):67-70. PubMed ID: 10572758 [No Abstract] [Full Text] [Related] [Next] [New Search]